Skip to main content
. 2019 Jul 23;36(2):105–113. doi: 10.1007/s12055-019-00847-6

Table 4.

Linearized incidence rates of events in both the groups during follow-up

Sl no. Event (%/patient-year) BoMVR PoMVR
1 Late mortality 3% 2.1%
2 SVD 0.08% 0.02%
3 NSVD 0.09% 0.01%
4 IE 1.1% 0.2%
5 Re operation (all cause) 2.0% 0.4%
6 Thromboembolic events 0.6% 0.3%
7 Bleeding 1.5% 1.0%
8 Heart failure (not valve related) 1.3% 0.6%